<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Three cases of secondary (therapy-related) hematologic malignant conditions were identified among 95 children as old as 18 years of age; the cases were diagnosed between 1984 and 1990 and consisted of <z:hpo ids='HP_0006721'>acute lymphoblastic leukemia</z:hpo>, <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>), and <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (MDSs) </plain></SENT>
<SENT sid="1" pm="."><plain>They constituted 10% of <z:hpo ids='HP_0000001'>all</z:hpo> new cases of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> seen at the University Hospitals of Cleveland during this time and were not related to congenital factors </plain></SENT>
<SENT sid="2" pm="."><plain>The primary malignant conditions were malignant thoracopulmonary <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> (<z:e sem="disease" ids="C0877849" disease_type="Neoplastic Process" abbrv="">Askin tumor</z:e>), <z:hpo ids='HP_0003006'>neuroblastoma</z:hpo>, and Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>The secondary <z:e sem="disease" ids="C1521860" disease_type="Disease or Syndrome" abbrv="">hematologic disorders</z:e> <z:hpo ids='HP_0000001'>all</z:hpo> showed a prominent monocytic component: <z:hpo ids='HP_0004845'>acute monocytic leukemia</z:hpo>, MDSs evolving to <z:hpo ids='HP_0004820'>acute myelomonocytic leukemia</z:hpo>, and <z:hpo ids='HP_0011010'>chronic</z:hpo> myelomonocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>The mean interval between treatment for the primary malignant condition and the <z:hpo ids='HP_0003674'>onset</z:hpo> of <z:e sem="disease" ids="C0277555" disease_type="Disease or Syndrome" abbrv="">secondary disease</z:e> was 36 months </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> had received <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi> and an epipodophyllotoxin for the <z:e sem="disease" ids="C0677930" disease_type="Neoplastic Process" abbrv="">primary tumor</z:e>; two were treated with radiation therapy </plain></SENT>
<SENT sid="6" pm="."><plain>Cytogenetic abnormalities included del(5), del(13), t(1;6), and t(9;11)(p22[symbol:see text]3) </plain></SENT>
<SENT sid="7" pm="."><plain>The survival time after the <z:hpo ids='HP_0003674'>onset</z:hpo> of <z:e sem="disease" ids="C0277555" disease_type="Disease or Syndrome" abbrv="">secondary disease</z:e> was short </plain></SENT>
</text></document>